Clinical Trial Details

SPIRRIT HFpEF

SPIRRIT HFpEF: Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Heart Failure with Preserved Ejection Fraction (HFpEF)
Study Type: Interventional
Phase: Phase IIII
Study Start Date: 11/23/2017
Study Completion Date: 12/2020

A Registry-based Randomized Clinical Trial (RRCT) to assess whether the initiation of spironolactone plus standard care compared to standard care alone improves outcomes in patients with Heart Failure with Preserved Ejection Fraction (HFpEF).

NCT Number

NCT02901184

Principal Investigator(s)

Geetha Pinto, MD

Sponsor(s)

Duke Clinical Research Institute

Participant Eligibility

• Age: 50 years or older
• Gender: Male, Female